Clinical Trial Update: The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating intravesical gemcitabine to prevent recurrence in urothelial carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Urothelial Carcinoma | Phase 2 | Status: UNKNOWN